Literature DB >> 33806489

Ophthalmologic Manifestations of Primary Sjögren's Syndrome.

Anna Maria Roszkowska1, Giovanni William Oliverio1, Emanuela Aragona2, Leandro Inferrera1, Alice Antonella Severo1, Federica Alessandrello1, Rosaria Spinella1, Elisa Imelde Postorino1, Pasquale Aragona1.   

Abstract

Sjögren's syndrome (SS) is a chronic, progressive, inflammatory, autoimmune disease, characterized by the lymphocyte infiltration of exocrine glands, especially the lacrimal and salivary, with their consequent destruction. The onset of primary SS (pSS) may remain misunderstood for several years. It usually presents with different types of severity, e.g., dry eye and dry mouth symptoms, due to early involvement of the lacrimal and salivary glands, which may be associated with parotid enlargement and dry eye; keratoconjunctivitis sicca (KCS) is its most common ocular manifestation. It is still doubtful if the extent ocular surface manifestations are secondary to lacrimal or meibomian gland involvement or to the targeting of corneal and conjunctival autoantigens. SS is the most representative cause of aqueous deficient dry eye, and the primary role of the inflammatory process was evidenced. Recent scientific progress in understanding the numerous factors involved in the pathogenesis of pSS was registered, but the exact mechanisms involved still need to be clarified. The unquestionable role of both the innate and adaptive immune system, participating actively in the induction and evolution of the disease, was recognized. The ocular surface inflammation is a central mechanism in pSS leading to the decrease of lacrimal secretion and keratoconjunctival alterations. However, there are controversies about whether the ocular surface involvement is a direct autoimmune target or secondary to the inflammatory process in the lacrimal gland. In this review, we aimed to present actual knowledge relative to the pathogenesis of the pSS, considering the role of innate immunity, adaptive immunity, and genetics.

Entities:  

Keywords:  Primary ocular Sjögren’s syndrome; adaptive immunity; innate immunity; pathogenesis

Mesh:

Year:  2021        PMID: 33806489      PMCID: PMC7998625          DOI: 10.3390/genes12030365

Source DB:  PubMed          Journal:  Genes (Basel)        ISSN: 2073-4425            Impact factor:   4.096


  167 in total

1.  Entropy of corneal nerve fibers distribution observed by laser scanning confocal microscopy: A noninvasive quantitative method to characterize the corneal innervation in Sjogren's syndrome patients.

Authors:  Giorgio Bianciardi; Maria Eugenia Latronico; Claudio Traversi
Journal:  Microsc Res Tech       Date:  2015-10-24       Impact factor: 2.769

2.  Mesenchymal stem/stromal cells protect the ocular surface by suppressing inflammation in an experimental dry eye.

Authors:  Min Joung Lee; Ah Young Ko; Jung Hwa Ko; Hyun Ju Lee; Mee Kum Kim; Won Ryang Wee; Sang In Khwarg; Joo Youn Oh
Journal:  Mol Ther       Date:  2014-08-25       Impact factor: 11.454

3.  A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.

Authors:  Dianne Petrone; John J Condemi; Rose Fife; Oscar Gluck; Stanley Cohen; Paul Dalgin
Journal:  Arthritis Rheum       Date:  2002-03

4.  Interferon-γ exacerbates dry eye-induced apoptosis in conjunctiva through dual apoptotic pathways.

Authors:  Xiaobo Zhang; Wei Chen; Cintia S De Paiva; Rosa M Corrales; Eugene A Volpe; Andrew J McClellan; William J Farley; De-Quan Li; Stephen C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-09       Impact factor: 4.799

5.  Use of adipose-derived mesenchymal stem cells in keratoconjunctivitis sicca in a canine model.

Authors:  Antonio J Villatoro; Viviana Fernández; Silvia Claros; Gustavo A Rico-Llanos; José Becerra; José A Andrades
Journal:  Biomed Res Int       Date:  2015-02-23       Impact factor: 3.411

6.  Significance and Implications of Patient-reported Xerostomia in Sjögren's Syndrome: Findings From the National Institutes of Health Cohort.

Authors:  Monisha Billings; Bruce A Dye; Timothy Iafolla; Alan N Baer; Margaret Grisius; Ilias Alevizos
Journal:  EBioMedicine       Date:  2016-09-09       Impact factor: 8.143

7.  Goblet Cells Contribute to Ocular Surface Immune Tolerance-Implications for Dry Eye Disease.

Authors:  Flavia L Barbosa; Yangyan Xiao; Fang Bian; Terry G Coursey; Byung Yi Ko; Hans Clevers; Cintia S de Paiva; Stephen C Pflugfelder
Journal:  Int J Mol Sci       Date:  2017-05-05       Impact factor: 5.923

8.  Reproducibility of Ocular Surface Staining in the Assessment of Sjögren Syndrome-Related Keratoconjunctivitis Sicca: Implications on Disease Classification.

Authors:  Astrid Rasmussen; Donald U Stone; C Erick Kaufman; Kimberly S Hefner; Nicole R Fram; Rhea L Siatkowski; Andrew J W Huang; James Chodosh; Pablo T Rasmussen; Dustin A Fife; Nathan Pezant; Kiely Grundahl; Lida Radfar; David M Lewis; Michael H Weisman; Swamy Venuturupalli; Daniel J Wallace; Nelson L Rhodus; Michael T Brennan; Courtney G Montgomery; Christopher J Lessard; R Hal Scofield; Kathy L Sivils
Journal:  ACR Open Rheumatol       Date:  2019-06-07

9.  Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort.

Authors:  Jacques-Eric Gottenberg; Raphaèle Seror; Corinne Miceli-Richard; Joelle Benessiano; Valerie Devauchelle-Pensec; Philippe Dieude; Jean-Jacques Dubost; Anne-Laure Fauchais; Vincent Goeb; Eric Hachulla; Pierre Yves Hatron; Claire Larroche; Véronique Le Guern; Jacques Morel; Aleth Perdriger; Xavier Puéchal; Stephanie Rist; Alain Saraux; Damien Sene; Jean Sibilia; Olivier Vittecoq; Gaétane Nocturne; Philippe Ravaud; Xavier Mariette
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240

10.  Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.

Authors:  Zhen Meng; Wannita Klinngam; Maria C Edman; Sarah F Hamm-Alvarez
Journal:  PLoS One       Date:  2017-09-13       Impact factor: 3.240

View more
  9 in total

1.  Short-Term Effects of a Novel Eye Mask Producing Heat and Vibration for the Treatment of Meibomian Gland Dysfunction: A Pilot Study.

Authors:  Luca Vigo; Marco Pellegrini; Francesco Carones; Vincenzo Scorcia; Giuseppe Giannaccare
Journal:  J Ophthalmol       Date:  2021-08-17       Impact factor: 1.909

2.  Neurotrophic Keratopathy in Systemic Diseases: A Case Series on Patients Treated With rh-NGF.

Authors:  Alessandro Meduri; Giovanni William Oliverio; Antonio Valastro; Claudia Azzaro; Umberto Camellin; Francesco Franchina; Leandro Inferrera; Anna Roszkowska; Pasquale Aragona
Journal:  Front Med (Lausanne)       Date:  2022-05-30

Review 3.  Anti-inflammatory Effects of GTE in Eye Diseases.

Authors:  Jian Li; Lin Du; Jing Na He; Kai On Chu; Cosmos Liutao Guo; Mandy Oi Man Wong; Chi Pui Pang; Wai Kit Chu
Journal:  Front Nutr       Date:  2021-12-13

4.  Efficacy of Intense Pulsed Light in the Treatment of Recurrent Chalaziosis.

Authors:  Yirui Zhu; Xiaodan Huang; Lin Lin; Mengshu Di; Ruida Chen; Jilian Dong; Xiuming Jin
Journal:  Front Med (Lausanne)       Date:  2022-03-01

5.  Changes of Dry Eye Parameters Especially Meibomian Gland Functions After Punctal Plugs Insertion in Aqueous-Deficient Dry Eye Patients.

Authors:  Tingting Liu; Shulin Liu; Meiqi Gan; Yuqin He; Hongxue Fu; Mei Xu
Journal:  Front Med (Lausanne)       Date:  2022-03-02

6.  Therapeutic effect of modified zengye decoction on primary Sjogren's syndrome and its effect on plasma exosomal proteins.

Authors:  Yimin Zeng; Xin Peng; Yun Wang; Lei Hou; Wukai Ma; Peng Yang
Journal:  Front Pharmacol       Date:  2022-08-26       Impact factor: 5.988

7.  The Extracts of Dendrobium Alleviate Dry Eye Disease in Rat Model by Regulating Aquaporin Expression and MAPKs/NF-κB Signalling.

Authors:  Jiawei Ling; Chung-Lap Chan; Chi-Yan Ho; Xun Gao; Sin-Man Tsang; Ping-Chung Leung; Jiang-Miao Hu; Chun-Kwok Wong
Journal:  Int J Mol Sci       Date:  2022-09-23       Impact factor: 6.208

8.  Special Issue: Autoimmune Disease Genetics.

Authors:  Malgorzata Gabriela Wasniewska; Artur Bossowski
Journal:  Genes (Basel)       Date:  2021-11-30       Impact factor: 4.096

9.  Systemic Treatment of Immune-Mediated Keratoconjunctivitis Sicca with Allogeneic Stem Cells Improves the Schirmer Tear Test Score in a Canine Spontaneous Model of Disease.

Authors:  Manuel Hermida-Prieto; Javier García-Castro; Luis Mariñas-Pardo
Journal:  J Clin Med       Date:  2021-12-20       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.